These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 10856536

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment.
    Cortellaro M, Cofrancesco E, Boschetti C, Cortellaro F, Mancini M, Mariani M, Paoletti R.
    Thromb Haemost; 2000 Apr; 83(4):549-53. PubMed ID: 10780315
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia and persistently high triglyceride levels.
    Spieker LE, Noll G, Hannak M, Lüscher TF.
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):361-5. PubMed ID: 10710119
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1996 Jan; 77A():28-32. PubMed ID: 8729588
    [Abstract] [Full Text] [Related]

  • 7. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 8. High-dose fluvastatin and bezafibrate combination treatment for heterozygous familial hypercholesterolemia.
    Eliav O, Schurr D, Pfister P, Friedlander Y, Leitersdorf E.
    Am J Cardiol; 1995 Jul 13; 76(2):76A-79A. PubMed ID: 7604804
    [Abstract] [Full Text] [Related]

  • 9. Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrate.
    Greten H, Beil FU, Schneider J, Weisweiler P, Armstrong VW, Keller C, Klör HU, von Hodenberg E, Weidinger G, Eskötter H.
    Am J Med; 1994 Jun 06; 96(6A):55S-63S. PubMed ID: 8017468
    [Abstract] [Full Text] [Related]

  • 10. Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia. French Fluvastatin Study Group.
    Farnier M, Dejager S.
    Am J Cardiol; 2000 Jan 01; 85(1):53-7. PubMed ID: 11078237
    [Abstract] [Full Text] [Related]

  • 11. Open-label study to assess the efficacy, safety, and tolerability of fluvastatin versus bezafibrate for hypercholesterolemia.
    Fanghänel G, Espinosa J, Olivares D, Sánchez L, Morales M, Martínez L, Macías G, Valdés E, Hernández G.
    Am J Cardiol; 1995 Jul 13; 76(2):57A-61A. PubMed ID: 7604800
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil).
    Farnier M, Salko T, Isaacsohn JL, Troendle AJ, Dejager S, Gonasun L.
    Am J Cardiol; 2003 Oct 01; 92(7):794-7. PubMed ID: 14516878
    [Abstract] [Full Text] [Related]

  • 14. Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage.
    Smit JW, Jansen GH, de Bruin TW, Erkelens DW.
    Am J Cardiol; 1995 Jul 13; 76(2):126A-128A. PubMed ID: 7604787
    [Abstract] [Full Text] [Related]

  • 15. Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease.
    Papadakis JA, Ganotakis ES, Jagroop IA, Winder AF, Mikhailidis DP.
    Int J Cardiol; 1999 Jun 01; 69(3):237-44. PubMed ID: 10402106
    [Abstract] [Full Text] [Related]

  • 16. Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia.
    Kehely A, MacMahon M, Barbir M, Wray R, Hunt BJ, Prescott RJ, Thompson GR.
    QJM; 1995 Jun 01; 88(6):421-7. PubMed ID: 7648234
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of fluvastatin in hypertensive patients. An analysis of a clinical trial database.
    Peters TK, Mehra M, Muratti EN.
    Am J Hypertens; 1993 Nov 01; 6(11 Pt 2):340S-345S. PubMed ID: 8297542
    [Abstract] [Full Text] [Related]

  • 19. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.
    Jacotot B, Benghozi R, Pfister P, Holmes D.
    Am J Cardiol; 1995 Jul 13; 76(2):54A-56A. PubMed ID: 7604799
    [Abstract] [Full Text] [Related]

  • 20. Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia.
    Gómez-Gerique JA, Ros E, Oliván J, Mostaza JM, Vilardell M, Pintó X, Civeira F, Hernández A, da Silva PM, Rodriguez-Botaro A, Zambón D, Lima J, Díaz C, Aristegui R, Sol JM, Chaves J, Hernández G, ATOMIX Investigators.
    Atherosclerosis; 2002 Jun 13; 162(2):245-51. PubMed ID: 11996943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.